Martin Treder
- Oncology top 10%
- Immunology top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Hematology top 10%
- Co-authors
- Uwe ReuschAxel UllrichJoachim KochErich RajkovicAxel ChoidasThorsten GantkeKarl DrlicaAnil Koul
- Topics
- Monoclonal and Polyclonal Antibodies Research (21 papers)CAR-T cell therapy research (14 papers)Immune Cell Function and Interaction (13 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Martin Treder
30 papers receiving 618 citations
Peers
Comparison fields: 5 of 62
- Oncology 351
- Immunology 283
- Molecular Biology 251
- Radiology, Nuclear Medicine and Imaging 205
- Hematology 77
Countries citing papers authored by Martin Treder
This map shows the geographic impact of Martin Treder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Treder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Treder more than expected).
Fields of papers citing papers by Martin Treder
This network shows the impact of papers produced by Martin Treder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Treder. The network helps show where Martin Treder may publish in the future.
Co-authorship network of co-authors of Martin Treder
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Treder. A scholar is included among the top collaborators of Martin Treder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Treder. Martin Treder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 104 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 25 | |
| 8 | 46 | |
| 9 | 3 | |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 17 | |
| 16 | Fully human Anti-HER3 monoclonal antibodies (mAbs) have unique in vitro and in vivo functional and antitumor activities versus other HER family inhibitors | 19 |
| 17 | Fully human Anti-HER3 monoclonal antibodies (mAbs) inhibit oncogenic signaling and tumor cell growth in vitro and in vivo | 14 |
| 18 | 15 | |
| 19 | 45 | |
| 20 | 156 |
About Martin Treder
Martin Treder is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 33 papers that have together received 642 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (21 papers), CAR-T cell therapy research (14 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Immunology (283 citations), Oncology (351 citations) and Radiology, Nuclear Medicine and Imaging (205 citations). Martin Treder has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Uwe Reusch, Axel Ullrich, Joachim Koch, Erich Rajkovic, Axel Choidas, Thorsten Gantke, Karl Drlica, Anil Koul, Akhilesh K. Tyagi and Yogendra Singh. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.